I am Head of AI/ML Product and Interim Head of AI at Absci, where I support a team comprising AI scientists, engineers, computational biologists, and product managers to bring precision antibody therapeutics to patients faster via AI-powered drug discovery and creation. 

Previously I was an AI/ML Product Manager at PathAI, where I led product development and translational science for their flagship AI digital pathology products in metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), a liver disease with poor prognosis. I hope that the tools we built will help identify effective therapies and improve outcomes for MASH patients. One of them has been qualified by the FDA for clinical trial endpoint assessment.

​

Prior to joining PathAI, I completed a PhD in Speech and Hearing Bioscience and Technology (SHBT) at Harvard University. I designed, fabricated, and patented an endomicroscope that visualizes cells inside the cochlea— the small, snail-shaped organ that shelters the primary sensory receptors for hearing. I hope that our device will improve diagnostics for deafness, the most common sensory deficit in the world.

​